Jay Robins
About Jay Robins
Jay Robins is the Vice President of Global Finance at BeiGene, with a robust background in finance and business planning across multiple biotech companies.
Title and Current Role
Jay Robins holds the position of Vice President Global Finance at BeiGene. In this role, he oversees financial strategies and operations, particularly focusing on clinical and commercial expansion post-IPO. His responsibilities include implementing enterprise resource planning (ERP) systems and shaping accounting policies, essential for BeiGene's ongoing growth.
Professional Experience
Jay has accumulated extensive experience in finance and business planning across several notable biotechnology and finance companies. Prior to his current role, he served as Vice President Finance at Merus N.V. from 2017 to 2019, and as Senior Director, Finance & Business Planning at Epizyme from 2015 to 2017. Between 2009 and 2015, he worked at Setem Technologies as Director, Finance & Operations. Early in his career, Jay was Manager of Thyrogen Commercial Operations at Genzyme and held equity research analyst positions at Deutsche Bank and Wachovia.
Educational Background
Jay Robins holds two advanced degrees from the Massachusetts Institute of Technology (MIT). He earned a Master of Science (MS) in Health Sciences & Technology and an MBA from the Biomedical Enterprise Program. These qualifications have equipped him with a robust foundation in both scientific and business disciplines, enhancing his ability to navigate the complex landscape of global finance in the biotechnology sector.
Achievements in the Biotechnology Sector
Jay has led key financial initiatives such as raising capital through IPOs, secondary offerings, private placements, and debt. He has been instrumental in the commercialization and global launch of three oncology products. In addition to these achievements, Jay has a significant track record of managing commercial partnerships and development, particularly in China.
Expertise in Corporate and Financial Strategy
Jay's expertise spans a range of critical financial and corporate strategies. He has conducted due diligence and crafted term-sheets for in-licensing and out-licensing of assets at various stages of development. His skills in formulating investment theses and investor relations strategies have been pivotal in supporting defense planning and collaboration opportunities. Jay's analytical capabilities in corporate valuation have also aided in effective alliance collaborations and partnerships.